491 related articles for article (PubMed ID: 21350196)
1. Apolipoprotein E induces antiinflammatory phenotype in macrophages.
Baitsch D; Bock HH; Engel T; Telgmann R; Müller-Tidow C; Varga G; Bot M; Herz J; Robenek H; von Eckardstein A; Nofer JR
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1160-8. PubMed ID: 21350196
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice.
Du F; Yu F; Wang Y; Hui Y; Carnevale K; Fu M; Lu H; Fan D
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):759-67. PubMed ID: 24504735
[TBL] [Abstract][Full Text] [Related]
3. Lack of mitogen-activated protein kinase phosphatase-1 protects ApoE-null mice against atherosclerosis.
Shen J; Chandrasekharan UM; Ashraf MZ; Long E; Morton RE; Liu Y; Smith JD; DiCorleto PE
Circ Res; 2010 Mar; 106(5):902-10. PubMed ID: 20093631
[TBL] [Abstract][Full Text] [Related]
4. Macrophage beta3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFalpha expression.
Schneider JG; Zhu Y; Coleman T; Semenkovich CF
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2699-706. PubMed ID: 17951320
[TBL] [Abstract][Full Text] [Related]
5. The Anti-Atherosclerotic Effects of Buyang Huanwu Decoction through M1 and M2 Macrophage Polarization in an ApoE Knockout Mouse Model.
Ji M; Mao L; Wei Y; Zhu B; Zhai Y; Zhou X; Tao W; Wang W; Wu H
J Physiol Investig; 2024 Mar; 67(2):79-87. PubMed ID: 38780292
[TBL] [Abstract][Full Text] [Related]
6. Mediator 1 Is Atherosclerosis Protective by Regulating Macrophage Polarization.
Bai L; Li Z; Li Q; Guan H; Zhao S; Liu R; Wang R; Zhang J; Jia Y; Fan J; Wang N; Reddy JK; Shyy JY; Liu E
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1470-1481. PubMed ID: 28642237
[TBL] [Abstract][Full Text] [Related]
7. Low density receptor-related protein 1 (LRP1) promotes anti-inflammatory phenotype in murine macrophages.
May P; Bock HH; Nofer JR
Cell Tissue Res; 2013 Dec; 354(3):887-9. PubMed ID: 23963646
[TBL] [Abstract][Full Text] [Related]
8. Augmented atherogenesis in LDL receptor deficient mice lacking both macrophage ABCA1 and ApoE.
Lammers B; Zhao Y; Hoekstra M; Hildebrand RB; Ye D; Meurs I; Van Berkel TJ; Van Eck M
PLoS One; 2011; 6(10):e26095. PubMed ID: 22022523
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice.
Grainger DJ; Reckless J; McKilligin E
J Immunol; 2004 Nov; 173(10):6366-75. PubMed ID: 15528376
[TBL] [Abstract][Full Text] [Related]
10. IgE Contributes to Atherosclerosis and Obesity by Affecting Macrophage Polarization, Macrophage Protein Network, and Foam Cell Formation.
Zhang X; Li J; Luo S; Wang M; Huang Q; Deng Z; de Febbo C; Daoui A; Liew PX; Sukhova GK; Metso J; Jauhiainen M; Shi GP; Guo J
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):597-610. PubMed ID: 31996021
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory immune skewing is atheroprotective: Apoe−/−FcγRIIb−/− mice develop fibrous carotid plaques.
Harmon EY; Fronhofer V; Keller RS; Feustel PJ; Zhu X; Xu H; Avram D; Jones DM; Nagarajan S; Lennartz MR
J Am Heart Assoc; 2014 Dec; 3(6):e001232. PubMed ID: 25516435
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 receptor type-1 in non-hematopoietic cells is the target for the pro-atherogenic effects of interleukin-1 in apoE-deficient mice.
Shemesh S; Kamari Y; Shaish A; Olteanu S; Kandel-Kfir M; Almog T; Grosskopf I; Apte RN; Harats D
Atherosclerosis; 2012 Jun; 222(2):329-36. PubMed ID: 22236482
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function.
Mehta NU; Grijalva V; Hama S; Wagner A; Navab M; Fogelman AM; Reddy ST
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1152-63. PubMed ID: 27079878
[TBL] [Abstract][Full Text] [Related]
14. Essential role for the (hepatic) LDL receptor in macrophage apolipoprotein E-induced reduction in serum cholesterol levels and atherosclerosis.
Van Eck M; Van Dijk KW; Herijgers N; Hofker MH; Groot PH; Van Berkel TJ
Atherosclerosis; 2001 Jan; 154(1):103-12. PubMed ID: 11137088
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-κB-driven inflammation and atherosclerosis.
Li K; Ching D; Luk FS; Raffai RL
Circ Res; 2015 Jun; 117(1):e1-e11. PubMed ID: 25904598
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow transplantation in apolipoprotein E-deficient mice. Effect of ApoE gene dosage on serum lipid concentrations, (beta)VLDL catabolism, and atherosclerosis.
Van Eck M; Herijgers N; Yates J; Pearce NJ; Hoogerbrugge PM; Groot PH; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3117-26. PubMed ID: 9409301
[TBL] [Abstract][Full Text] [Related]
17. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
[TBL] [Abstract][Full Text] [Related]
18. Very-low-density lipoprotein binding to the apolipoprotein E receptor 2 is enhanced by lipoprotein lipase, and does not require apolipoprotein E.
Tacken PJ; Beer FD; Vark LC; Havekes LM; Hofker MH; Willems Van Dijk K
Biochem J; 2000 Apr; 347(Pt 2):357-61. PubMed ID: 10749663
[TBL] [Abstract][Full Text] [Related]
19. Luteolin Alters Macrophage Polarization to Inhibit Inflammation.
Wang S; Cao M; Xu S; Shi J; Mao X; Yao X; Liu C
Inflammation; 2020 Feb; 43(1):95-108. PubMed ID: 31673976
[TBL] [Abstract][Full Text] [Related]
20. SOCS3 deficiency promotes M1 macrophage polarization and inflammation.
Qin H; Holdbrooks AT; Liu Y; Reynolds SL; Yanagisawa LL; Benveniste EN
J Immunol; 2012 Oct; 189(7):3439-48. PubMed ID: 22925925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
